Literature DB >> 4607731

The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder.

D Greenwood, F O'Grady.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4607731      PMCID： PMC2072632     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  10 in total

1.  The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1972-10

2.  Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder.

Authors:  F O'Grady; I P Mackintosh; D Greenwood; B W Watson
Journal:  Br J Exp Pathol       Date:  1973-06

3.  Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.

Authors:  D Greenwood; F O'Grady
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

4.  Mucopeptide hydrolases and bacterial "persisters".

Authors:  D Greenwood
Journal:  Lancet       Date:  1972-09-02       Impact factor: 79.321

5.  Development and further applications of a simple turbidity cell for continuously monitoring bacterial growth.

Authors:  I P Mackintosh; B W Watson; F O'Grady
Journal:  Phys Med Biol       Date:  1973-03       Impact factor: 3.609

6.  Trimodal response of Escherichia coli and Proteus mirabilis to penicillins.

Authors:  D Greenwood; F O'Grady
Journal:  Nature       Date:  1970-10-31       Impact factor: 49.962

7.  Interaction of cephaloridine with penicillinase-producing gram-negative bacteria.

Authors:  J M Hamilton-Miller; J T Smith; R Knox
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

8.  A comparative study of eight distinct beta-lactamases synthesized by gram-negative bacteria.

Authors:  G W Jack; M H Richmond
Journal:  J Gen Microbiol       Date:  1970-04

9.  Laoratory appraisal of cephalexin.

Authors:  P W Muggleton; C H O'Callaghan; R D Foord; S M Kirby; D M Ryan
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

10.  Some relationships between R-factor and chromosomal -lactamase in Gram-negative bacteria.

Authors:  J W Dale; J T Smith
Journal:  Biochem J       Date:  1971-07       Impact factor: 3.857
  10 in total
  8 in total

1.  Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1975-04

2.  Letter: Co-trimoxazole and cephalexin in urinary tract infection.

Authors:  D Greenwood; F O'Grady
Journal:  Br Med J       Date:  1976-05-01

3.  Activity of cefazolin against dense populations of enterobacteria.

Authors:  D Greenwood; C H Chan-Teoh; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

4.  Factors influencing the response of Escherichia coli to antibiotics in conditions prevailing in the infected urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1976-06

5.  Resolving Fast, Confined Diffusion in Bacteria with Image Correlation Spectroscopy.

Authors:  David J Rowland; Hannah H Tuson; Julie S Biteen
Journal:  Biophys J       Date:  2016-05-24       Impact factor: 4.033

6.  Dual-action cephalosporin utilizing a novel therapeutic principle.

Authors:  D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

7.  Use of polyvinylpyrrolidone in the testing of staphylococci for sensitivity to methicillin and cephradine.

Authors:  R Bayston
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

8.  Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli.

Authors:  D Greenwood; F O'Grady
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.